349 related articles for article (PubMed ID: 36241233)
1. [Bioactive compounds of Jingfang Granules against SARS-CoV-2 virus proteases 3CL
Shang ZP; Yi Y; Yu R; Fan JJ; Huang YX; Qiao X; Ye M
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):907-919. PubMed ID: 36241233
[TBL] [Abstract][Full Text] [Related]
2. Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds.
Khanal P; Patil VS; Bhandare VV; Dwivedi PSR; Shastry CS; Patil BM; Gurav SS; Harish DR; Roy S
Comput Biol Med; 2022 Jul; 146():105668. PubMed ID: 35667894
[TBL] [Abstract][Full Text] [Related]
3. Chrysin 7-O-β-D-glucuronide, a dual inhibitor of SARS-CoV-2 3CL
Yi Y; Yu R; Xue H; Jin Z; Zhang M; Bao YO; Wang Z; Wei H; Qiao X; Yang H
Int J Antimicrob Agents; 2024 Jan; 63(1):107039. PubMed ID: 37981073
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
5. Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
De Marco Verissimo C; López Corrales J; Dorey AL; Cwiklinski K; Lalor R; Calvani NED; Jewhurst HL; Flaus A; Doyle S; Dalton JP
Epidemiol Infect; 2022 Jun; 150():e128. PubMed ID: 35723031
[TBL] [Abstract][Full Text] [Related]
6. Schaftoside inhibits 3CL
Yi Y; Zhang M; Xue H; Yu R; Bao YO; Kuang Y; Chai Y; Ma W; Wang J; Shi X; Li W; Hong W; Li J; Muturi E; Wei H; Wlodarz J; Roszak S; Qiao X; Yang H; Ye M
Acta Pharm Sin B; 2022 Nov; 12(11):4154-4164. PubMed ID: 35968270
[TBL] [Abstract][Full Text] [Related]
7. Identification of Phytochemicals from Arabian Peninsula Medicinal Plants as Strong Binders to SARS-CoV-2 Proteases (3CL
Saquib Q; Bakheit AH; Ahmed S; Ansari SM; Al-Salem AM; Al-Khedhairy AA
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474509
[TBL] [Abstract][Full Text] [Related]
8. Fluorine Atoms on C
Chaves OA; Rodrigues-Santos CE; Echevarria Á; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Castro-Faria-Neto HC; Souza TMLE
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142848
[TBL] [Abstract][Full Text] [Related]
9. An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2.
Pennisi R; Gentile D; Rescifina A; Napoli E; Trischitta P; Piperno A; Sciortino MT
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254643
[TBL] [Abstract][Full Text] [Related]
10. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM
Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962
[TBL] [Abstract][Full Text] [Related]
11. Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL
Jade D; Ayyamperumal S; Tallapaneni V; Joghee Nanjan CM; Barge S; Mohan S; Nanjan MJ
Eur J Pharmacol; 2021 Jun; 901():174082. PubMed ID: 33823185
[TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum.
Gyebi GA; Elfiky AA; Ogunyemi OM; Ibrahim IM; Adegunloye AP; Adebayo JO; Olaiya CO; Ocheje JO; Fabusiwa MM
Comput Biol Med; 2021 Sep; 136():104671. PubMed ID: 34332348
[TBL] [Abstract][Full Text] [Related]
13. Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses.
Wang R; Zhai G; Zhu G; Wang M; Gong X; Zhang W; Ge G; Chen H; Chen L
Bioorg Chem; 2023 Jan; 130():106264. PubMed ID: 36395603
[TBL] [Abstract][Full Text] [Related]
14. Effects of diarylbutane lignans from
Li B; Qiao L; Xiao Q; Zhang J; Liu J; Zhang B; Liu H
Phytomed Plus; 2023 May; 3(2):100432. PubMed ID: 36968623
[TBL] [Abstract][Full Text] [Related]
15. Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL
Ma L; Xie Y; Zhu M; Yi D; Zhao J; Guo S; Zhang Y; Wang J; Li Q; Wang Y; Cen S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555652
[TBL] [Abstract][Full Text] [Related]
16. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
[TBL] [Abstract][Full Text] [Related]
17. Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.
Brier L; Hassan H; Hanoulle X; Landry V; Moschidi D; Desmarets L; Rouillé Y; Dumont J; Herledan A; Warenghem S; Piveteau C; Carré P; Ikherbane S; Cantrelle FX; Dupré E; Dubuisson J; Belouzard S; Leroux F; Deprez B; Charton J
Eur J Med Chem; 2023 Mar; 250():115186. PubMed ID: 36796300
[TBL] [Abstract][Full Text] [Related]
18. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL
Mouffouk C; Mouffouk S; Mouffouk S; Hambaba L; Haba H
Eur J Pharmacol; 2021 Jan; 891():173759. PubMed ID: 33249077
[TBL] [Abstract][Full Text] [Related]
19. In Silico Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease.
Miwa K; Guo Y; Hata M; Hirano Y; Yamamoto N; Hoshino T
Chem Pharm Bull (Tokyo); 2023; 71(12):897-905. PubMed ID: 38044142
[TBL] [Abstract][Full Text] [Related]
20. Polyphenolic Compounds Isolated from Marine Algae Attenuate the Replication of SARS-CoV-2 in the Host Cell through a Multi-Target Approach of 3CL
Nagahawatta DP; Liyanage NM; Je JG; Jayawardhana HHACK; Jayawardena TU; Jeong SH; Kwon HJ; Choi CS; Jeon YJ
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
